BUSINESS ACQUISITIONS (Tables)

6 Months Ended

Jun. 30, 2015

Business acquisition

Schedule of unaudited pro forma results of operations

	Three Months Ended June 30,				Six Months Ended June 30,
	2015		2014		2015		2014
Net sales	$	913,199	$	730,414	$	1,709,610	$	1,322,128
Net income attributable to Diplomat Pharmacy, Inc.	$	8,090	$	2,899	$	15,567	$	4,106
Net income per common share — basic	$	0.13	$	0.08	$	0.26	$	0.11
Net income per common share — diluted	$	0.12	$	0.08	$	0.25	$	0.11

Burman's Apothecary, LLC

Business acquisition

Schedule of consideration transferred

Cash	$	84,296
253,036 restricted common shares	9,578
	$	93,874

Summary of the amounts of identifiable acquired assets and assumed liabilities

Accounts receivable	$	17,274
Inventories	8,668
Prepaid expenses and other current assets	7,514
Property and equipment	49
Capitalized software for internal use	18,000
Intangible assets	24,400
Current liabilities	(25,797		)
Total identifiable net assets	50,108
Goodwill	43,766
	$	93,874

Schedule of definite-lived intangible assets that were acquired and their respective useful lives

	Useful Life	Amount
Physician relationships	12 years	$	16,000
Non-compete employment agreements	5 years	5,700
Favorable supply agreement	1 year	2,700
		$	24,400

BioRx, LLC

Business acquisition

Schedule of consideration transferred

Cash at closing	$	217,467
4,038,853 restricted common shares	125,697
Contingent consideration at fair value	37,000
Receivable for estimated post-closing adjustment	(619		)
	$	379,545

Summary of the amounts of identifiable acquired assets and assumed liabilities

Cash and cash equivalents	$	1,786
Accounts receivable	42,131
Inventories	5,546
Prepaid expenses and other current assets	669
Property and equipment	494
Other noncurrent assets	162
Intangible assets	182,000
Liabilities	(36,873		)
Total identifiable net assets	195,915
Goodwill	183,630
	$	379,545

Schedule of definite-lived intangible assets that were acquired and their respective useful lives

	Useful Life	Amount
Patient relationships	10 years	$	130,000
Non-compete employment agreements	5 years	39,700
Trade names and trademarks	8 years	12,300
		$	182,000

MedPro Rx, Inc.

Business acquisition

Schedule of consideration transferred

Cash	$	52,267
716,695 restricted common shares	12,000
Contingent consideration at fair value	4,270
	$	68,537

Summary of the amounts of identifiable acquired assets and assumed liabilities

Cash and cash equivalents	$	668
Accounts receivable	9,050
Inventories	3,819
Prepaid expenses and other current assets	204
Property and equipment	697
Capitalized software for internal use	25
Intangible assets	37,099
Current liabilities	(4,660		)
Total identifiable net assets	46,902
Goodwill	21,635
	$	68,537

Schedule of definite-lived intangible assets that were acquired and their respective useful lives

	Useful Life	Amount
Patient relationships	7 years	$	24,000
Trade names and trademarks	10 years	8,700
Non-compete employment agreements	5 years	4,399
		$	37,099